Iftakhar Ahmed
About Iftakhar Ahmed
Iftakhar Ahmed is a Sales and Business Development Manager at SOPHiA GENETICS, with extensive experience in the biotechnology and pharmaceutical sectors. He has held various sales and managerial positions at several companies, including Eurofins Genomics and Takara Bio Europe, and possesses expertise in Next-Generation Sequencing and laboratory automation.
Current Role at SOPHiA GENETICS
Iftakhar Ahmed serves as the Sales and Business Development Manager at SOPHiA GENETICS. He has held this position since 2020, contributing to the company's growth in the United Kingdom. His role involves developing sales strategies and managing client relationships within the genomics sector.
Previous Experience in Biotechnology Sales
Prior to his current role, Iftakhar Ahmed worked at Eurofins Genomics as a Genomics Account Manager for four months in 2020. He also held the position of Territory Manager at Takara Bio Europe from 2014 to 2019, where he focused on sales in the UK. His experience includes a brief tenure as a Technical Sales Specialist at Markes International in 2019.
Sales Management Background
Iftakhar Ahmed has a strong background in sales management within the biotechnology and pharmaceutical industries. His career includes roles such as UK Sales Engineer at AMETEK Advanced Measurement Technologies and Sales Specialist at VWR. He has also worked as a Sales Manager for Gel Company and as a Sales Representative at Labcaire Systems Ltd.
Educational Qualifications
Iftakhar Ahmed studied at Nottingham Trent University, where he earned a Bachelor's degree in Applied Biology from 1993 to 1997. He furthered his education by obtaining a Master’s Degree in Biotechnology from the same institution in 1999.
Expertise in Genomics and Laboratory Technologies
Iftakhar Ahmed possesses expertise in Next-Generation Sequencing (NGS) and DNA Sequencing technologies. He is skilled in laboratory automation and medical devices, which supports his effectiveness in sales and business development within the life sciences sector.